{"version":"1.0","provider_name":"Cilcare","provider_url":"https:\/\/www.cilcare.com\/jp","title":"CILcare and Knotus partner to accelerate the development of novel therapies to prevent and treat ear disorders in Korean and Asian market - Cilcare","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"xboI3fFQzD\"><a href=\"https:\/\/www.cilcare.com\/jp\/2021\/06\/07\/cilcare-knotus-partnership\/\">CILcare and Knotus partner to accelerate the development of novel therapies to prevent and treat ear disorders in Korean and Asian market<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.cilcare.com\/jp\/2021\/06\/07\/cilcare-knotus-partnership\/embed\/#?secret=xboI3fFQzD\" width=\"600\" height=\"338\" title=\"&#8220;CILcare and Knotus partner to accelerate the development of novel therapies to prevent and treat ear disorders in Korean and Asian market&#8221; &#8212; Cilcare\" data-secret=\"xboI3fFQzD\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.cilcare.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","thumbnail_url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2021\/06\/Illustration-PR-Knotus-partnership-v2.png","thumbnail_width":1920,"thumbnail_height":1080,"description":"Montpellier\u00a0&amp; Seoul, June 8th, 2021: CILcare, the world\u2019s leading CRO dedicated to ear disorders, and Knotus, a leading Korean\u00a0non-clinical\u00a0CRO, announced today that they have entered into a strategic partnership that aims at\u00a0accelerating\u00a0the development of therapeutics\u00a0to\u00a0prevent and treat hearing disorders. CILcare and\u00a0Knotus\u00a0will be working together to\u00a0propose to\u00a0pharmaceutical, veterinary,\u00a0nutraceutical\u00a0and medical devices\u00a0industries\u00a0CILcare\u2019s\u00a0cutting-edge R&amp;D services to support safety and efficacy evidence of their\u00a0products\u00a0on auditory functions. Hearing loss\u00a0is a\u00a0global unmet medical need\u00a0that concerns 1.5 billion people\u00a0worldwide,\u00a0with a prevalence\u00a0increasing\u00a0dramatically\u00a0stemming from\u00a0aging population, noise exposure and\u00a0auditory side-effects of multiple drugs. In 2050, 2.5 billion people will suffer from hearing loss according to the latest WHO forecasts, and the highest rise will be observed in Western\u00a0Pacific\u00a0Region.\u00a0\u00a0\u00a0\u00a0 As there\u00a0are\u00a0still no [&hellip;]"}